For research use only
| Cat No. | ABC-X0140C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Epithelial-like |
| Species | Human |
| Host Cell | MC38 |
| Source Organ | Colon |
| Disease | Colon Adenocarcinoma |
| Storage | Liquid Nitrogen |
The Xpress™ human CD66e overexpressing cell line (MC38) provides a powerful model for tumor research, supporting CEACAM5 targeted therapies.
Xpress™ Human CD66e over-expressing cell line (MC38) is a genetically engineered model derived from selected murine MC38 parental cell line based on customers’ requirement. Human CD66e overexpression cell line is generated by stable integration of exogenous human CD66e gene into MC38 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
CD66e (also known as CEACAM5 or CEA) is a cell adhesion molecule frequently overexpressed in colorectal, pancreatic, and lung cancers. It facilitates tumor growth, metastasis, and resistance to apoptosis, making it a prominent tumor-associated antigen for targeted therapies. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0140C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Colon |
| Disease | Colon Adenocarcinoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | MC38 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The Xpress™ Human CD66e over-expressing cell line (MC38) serves as a robust model for tumor antigen research, therapeutic antibody validation, and targeted drug screening. It supports development of CEACAM5-targeted approaches such as bispecific antibodies and CAR-T cells.